Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dale

Showing results (231-240 of 283) with videos related to

Pageof 29
Sort By:
Biorxiv : the Preprint Server for Biology|June 19, 2023
Integrated spatiotemporal transcriptomic resolution of embryonic palate osteogenesisJeremie Oliver Piña, Resmi Raju, Daniela M Roth, et al.
American Journal of Hematology|August 4, 2007
Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndromeV Koneti Rao, Kennichi C Dowdell, Janet K Dale, et al.
The Journal of Allergy and Clinical Immunology|March 16, 2010
Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndromeIusta Caminha, Thomas A Fleisher, Ronald L Hornung, et al.
Nature Genetics|January 30, 2023
Enhancer-promoter interactions can bypass CTCF-mediated boundaries and contribute to phenotypic robustnessShreeta Chakraborty, Nina Kopitchinski, Zhenyu Zuo, et al.
BMC Medical Genetics|July 4, 2007
Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type IbLilia L Bi, George Pan, T Prescott Atkinson, et al.
Bone Reports|July 25, 2022
<i>SMAD3</i> mutation in LDS3 causes bone fragility by impairing the TGF-β pathway and enhancing osteoclastogenesisAhmed El-Gazzar, Heeseog Kang, Nadja Fratzl-Zelman, et al.
Epidemiology (Cambridge, Mass.)|November 26, 2024
Multilevel Resilience and Appointment Attendance Among African American/Black Adults with HIV: A Prospective Multisite Cohort StudyMarta G Wilson-Barthes, Jee Won Park, Michael J Mugavero, et al.
AIDS and Behavior|January 29, 2022
Development of Long and Short Forms of the Multilevel Resilience Resource Measure for African American/Black Adults Living with HIVAkilah J Dulin, Joseph L Fava, Valerie A Earnshaw, et al.
Genome Biology|April 26, 2012
Mediation of Drosophila autosomal dosage effects and compensation by network interactionsJohn H Malone, Dong-Yeon Cho, Nicolas R Mattiuzzo, et al.
American Journal of Public Health|June 28, 2022
Monitoring Intersectional Stigma: A Key Strategy to Ending the HIV Epidemic in the United StatesCristina Rodriguez-Hart, Cheriko A Boone, Ana María Del Río-González, et al.
Pageof 29

Showing results (231-240 of 283) with videos related to

Sort By:
Pageof 29
Biorxiv : the Preprint Server for Biology|June 19, 2023
Integrated spatiotemporal transcriptomic resolution of embryonic palate osteogenesisJeremie Oliver Piña, Resmi Raju, Daniela M Roth, et al.
American Journal of Hematology|August 4, 2007
Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndromeV Koneti Rao, Kennichi C Dowdell, Janet K Dale, et al.
The Journal of Allergy and Clinical Immunology|March 16, 2010
Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndromeIusta Caminha, Thomas A Fleisher, Ronald L Hornung, et al.
Nature Genetics|January 30, 2023
Enhancer-promoter interactions can bypass CTCF-mediated boundaries and contribute to phenotypic robustnessShreeta Chakraborty, Nina Kopitchinski, Zhenyu Zuo, et al.
BMC Medical Genetics|July 4, 2007
Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type IbLilia L Bi, George Pan, T Prescott Atkinson, et al.
Bone Reports|July 25, 2022
<i>SMAD3</i> mutation in LDS3 causes bone fragility by impairing the TGF-β pathway and enhancing osteoclastogenesisAhmed El-Gazzar, Heeseog Kang, Nadja Fratzl-Zelman, et al.
Epidemiology (Cambridge, Mass.)|November 26, 2024
Multilevel Resilience and Appointment Attendance Among African American/Black Adults with HIV: A Prospective Multisite Cohort StudyMarta G Wilson-Barthes, Jee Won Park, Michael J Mugavero, et al.
AIDS and Behavior|January 29, 2022
Development of Long and Short Forms of the Multilevel Resilience Resource Measure for African American/Black Adults Living with HIVAkilah J Dulin, Joseph L Fava, Valerie A Earnshaw, et al.
Genome Biology|April 26, 2012
Mediation of Drosophila autosomal dosage effects and compensation by network interactionsJohn H Malone, Dong-Yeon Cho, Nicolas R Mattiuzzo, et al.
American Journal of Public Health|June 28, 2022
Monitoring Intersectional Stigma: A Key Strategy to Ending the HIV Epidemic in the United StatesCristina Rodriguez-Hart, Cheriko A Boone, Ana María Del Río-González, et al.
Pageof 29